Mayo Clinic investigators validated an AI model that can detect pancreatic cancer from routine abdominal CT scans up to three years before clinical diagnosis. The approach identifies subtle imaging biomarkers and architectural changes that are difficult for human radiologists to consistently recognize. The validation extends prior work by focusing on earlier time windows, which is critical in pancreatic ductal adenocarcinoma where early-stage detection remains rare and survival is poor. The reported system supports detection on scans already obtained for other clinical reasons, offering a pathway toward opportunistic screening. For clinical practice and developers, the main implementation questions will be generalizability across imaging protocols, integration into radiology workflows, and prospective performance against standard-of-care screening strategies. Still, the validation timeline creates a near-term momentum for AI-based triage and risk stratification in high-incidence healthcare settings.